Patients with rosacea also exhibit abnormally high levels of kallikrein-5 (KLK5), a serine protease that processes CAMP into bioactive fragments such as LL-37, thereby amplifying the inflammatory cascade [9]. The gene discussed is KLK5; the disease is rosacea.